Sökning: onr:"swepub:oai:gup.ub.gu.se/55739" >
Impact of diabetes ...
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study
-
Okin, P. M. (författare)
-
Devereux, R. B. (författare)
-
Gerdts, E. (författare)
-
visa fler...
-
Snapinn, S. M. (författare)
-
Harris, K. E. (författare)
-
- Jern, Sverker, 1954 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin,Institute of Medicine, Department of Emergeny and Cardiovascular Medicine
-
Kjeldsen, S. E. (författare)
-
Julius, S. (författare)
-
Edelman, J. M. (författare)
-
Lindholm, L. H. (författare)
-
- Dahlöf, Björn, 1953 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin,Institute of Medicine, Department of Emergeny and Cardiovascular Medicine
-
visa färre...
-
(creator_code:org_t)
- 2006
- 2006
- Engelska.
-
Ingår i: Circulation. - 1524-4539. ; 113:12, s. 1588-96
- Relaterad länk:
-
https://gup.ub.gu.se...
Abstract
Ämnesord
Stäng
- BACKGROUND: Diabetes mellitus is associated with increased cardiovascular (CV) morbidity and mortality and with greater ECG left ventricular hypertrophy (LVH); however, it is unclear whether diabetes attenuates regression of hypertensive LVH and whether regression of ECG LVH has similar prognostic value in diabetic and nondiabetic hypertensive individuals. METHODS AND RESULTS: A total of 9193 hypertensive patients (1195 with diabetes) in the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study were treated with losartan- or atenolol-based regimens and followed up with serial ECG and blood pressure determinations at baseline and 6 months and then yearly until death or study end. ECG LVH was defined with gender-adjusted Cornell voltage-duration product (CP) criteria >2440 mm . ms. After a mean follow-up of 4.8+/-0.9 years, patients with diabetes had less regression of CP LVH (-138+/-866 versus -204+/-854 mm . ms, P<0.001), remained more likely to have LVH by CP (56.0% versus 48.1%, P<0.001), and had higher rates of CV death, myocardial infarction, stroke, and all-cause mortality and of the LIFE composite end point of CV death, myocardial infarction, or stroke. In multivariable Cox proportional hazards models, in-treatment regression or absence of ECG LVH by CP was associated with between 17% and 35% reductions in event rates in patients without diabetes but did not significantly predict outcome in patients with diabetes. CONCLUSIONS: Hypertensive patients with diabetes have less regression of CP LVH in response to antihypertensive therapy than patients without diabetes, and regression of ECG LVH is less useful as a surrogate marker of outcomes in hypertensive patients with diabetes. These findings may in part explain the higher CV morbidity and mortality in hypertensive patients with diabetes, and the absence of a demonstrable improvement in prognosis in diabetic patients in response to regression of ECG LVH suggests a more complex interrelation between underlying LV structural and functional abnormalities and outcome in these patients.
Nyckelord
- Aged
- Aged
- 80 and over
- Antihypertensive Agents/*pharmacology/therapeutic use
- Atenolol/pharmacology/therapeutic use
- Diabetes Complications/drug therapy/mortality/physiopathology
- Diabetes Mellitus/mortality/*physiopathology
- Double-Blind Method
- Electrocardiography
- Female
- Humans
- Hypertension/drug therapy/mortality
- Hypertrophy
- Left Ventricular/*drug therapy/mortality
- Losartan/pharmacology/therapeutic use
- Male
- Middle Aged
- Prognosis
- Treatment Outcome
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Okin, P. M.
-
Devereux, R. B.
-
Gerdts, E.
-
Snapinn, S. M.
-
Harris, K. E.
-
Jern, Sverker, 1 ...
-
visa fler...
-
Kjeldsen, S. E.
-
Julius, S.
-
Edelman, J. M.
-
Lindholm, L. H.
-
Dahlöf, Björn, 1 ...
-
visa färre...
- Artiklar i publikationen
-
Circulation
- Av lärosätet
-
Göteborgs universitet